SFOSF fundamentals
An in-depth look to Shanghai Fosun Pharmaceutical Group Co Ltd operating, investing, and financing activities
SFOSF free cash flow for H2 23 is -64.47 M USD. For 2023, SFOSF free cash flow was -314.23 M USD and operating cash flow was 440.77 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM